Myrcia ovata Cambessedes essential oils: A proposal for a novel natural antimicrobial against foodborne bacteria

Myrcia ovata Cambessedes essential oils: A proposal for a novel natural antimicrobial against foodborne bacteria

Accepted Manuscript Myrcia ovata Cambessedes essential oils: A proposal for a novel natural antimicrobial against foodborne bacteria Isabela Cristina ...

511KB Sizes 0 Downloads 82 Views

Accepted Manuscript Myrcia ovata Cambessedes essential oils: A proposal for a novel natural antimicrobial against foodborne bacteria Isabela Cristina de Jesus, Gladslene Góes Santos Frazão, Arie Fitzgerald Blank, Luciana Cristina Lins de Aquino Santana PII:

S0882-4010(16)30331-X

DOI:

10.1016/j.micpath.2016.08.023

Reference:

YMPAT 1922

To appear in:

Microbial Pathogenesis

Received Date: 16 June 2016 Revised Date:

18 July 2016

Accepted Date: 19 August 2016

Please cite this article as: de Jesus IC, Santos Frazão GG, Blank AF, de Aquino Santana LCL, Myrcia ovata Cambessedes essential oils: A proposal for a novel natural antimicrobial against foodborne bacteria, Microbial Pathogenesis (2016), doi: 10.1016/j.micpath.2016.08.023. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

ACCEPTED MANUSCRIPT 1

Myrcia ovata Cambessedes essential oils: A proposal for a novel natural

2

antimicrobial against foodborne bacteria

3 4

Isabela Cristina de Jesusa, Gladslene Góes Santos Frazãoa, Arie Fitzgerald Blankb,

6

Luciana Cristina Lins de Aquino Santanaa*

7

a

8

Rondon, S/N, São Cristóvão, Sergipe CEP 49100-000, Brazil.

9

b

SC

Department of Food Technology, Federal University of Sergipe, Av. Marechal

Department of Agronomy, Federal University of Sergipe, Av. Marechal Rondon, S/N,

M AN U

10

São Cristóvão, Sergipe CEP 49100-000, Brazil.

11

12

TE D

13 14

RI PT

5

*Corresponding author at: Federal University of Sergipe, Department of Food

16

Technology, Laboratory of Food Microbiology and Bioengineering, Avenida Marechal

17

Rondon s/n, CEP: 49100-000, São Cristóvão, Sergipe.

18

Tel.: + 55 79 2105 7420; Fax: +55 79 2105 6903.

19

Email address: [email protected]

21 22 23

AC C

20

EP

15

24 25 26 27 1

ACCEPTED MANUSCRIPT 28

ABSTRACT

29 30

This paper reports the innovative antibacterial activity of essential oils (EOs) from nine

32

Myrcia ovata Cambessedes plants against eight foodborne bacteria. Staphylococcus

33

aureus, Bacillus cereus, Bacillus subtilis, Enterococcus faecalis and Pseudomonas

34

aeruginosa were the most susceptible bacteria to EOs. In particular, the P. aeruginosa,

35

which is usually resistant to antimicrobials agents, was extremely sensitive to some

36

EOs. The gram-positive and gram-negative bacteria were inhibited and eliminated with

37

minimum EOs concentrations ranging from 0.78 to 25 µL/mL. The Serratia marcensces

38

and Escherichia coli were less susceptible to EOs alone. Consequently, some EOs

39

combinations were investigated by checkerboard method against these bacteria and a

40

synergistic effect was obtained. Myrcia ovata Cambessedes EOs showed high inhibitory

41

and bactericidal effects against foodborne bacteria might be an interesting alternative

42

for future applications as natural antimicrobials in food systems.

45

46 47 48 49

SC

M AN U

TE D

Keywords: antibacterial activity, essential oils, Myrcia ovata, antimicrobials.

EP

44

AC C

43

RI PT

31

50 51 52 53 54 2

ACCEPTED MANUSCRIPT 55 56

1. Introduction

57

Essential oils (EOs) are natural antimicrobials found in many plants and are

59

capable of decreasing growth and survival of microorganisms including bacteria and

60

fungi [1]. The antimicrobial activity of EOs is directly correlated with the presence of

61

their bioactive volatile components such as terpene compounds (mono-, sesqui- and

62

diterpenes), alcohols, acids, esters, epoxides, aldehydes, ketones, amines and sulphides

63

[2,3]. The antimicrobial action of EOs against bacteria may be attributed to their ability

64

to penetrate through bacterial membranes and inhibit functional and lipophilic

65

properties of the cell. Phenolic compounds found in EOs may alter microbial cell

66

permeability, damage cytoplasmic membranes, interfere with cellular energy (ATP)

67

generation systems and disrupt the proton motive force, resulting in cell death [1,2,4-6].

68

Over the years, a variety of EOs, such as oregano, thyme, cinnamon, orange,

69

marjoram, clove bud, lemon grass and others have shown antimicrobial activity against

70

bacteria and fungi [1]. Some essential oils as Satureja montana L., Thymus vulgaris L.

71

and Rosmarinus officinalis L. have been used in food industry as flavouring agents,

72

antioxidants and antimicrobials and in cosmetics industries [7,8]. The Myrcia ovata

73

Cambessedes, popularly known as “laranjinha do-Mato”, is a shrub about eight meters

74

tall and its leaves are commonly used in tea, folk medicin and treatment of gastric

75

illnesses, including gastritis and diarrhoea. Myrcia, comprising around 377 species, is

76

one of the largest genera in the Myrtaceae family recognized in the Brazilian cerrado

77

and Atlantic forests [9,10]. The antimicrobial activity of Myrcia ovata EO from plants

78

cultivated in Guaramiranga at Ceará State (Brazil) against microorganisms related to

79

gastric and intestinal disorders was studied by Cândido et al. [11]. In previous study,

AC C

EP

TE D

M AN U

SC

RI PT

58

3

ACCEPTED MANUSCRIPT 80

Sampaio et al. [12] also have reported the antifungal potential of some Myrcia ovata

81

EOs against Fusarium solani, a phytopathogenic fungi of importance in agriculture. The EOs have attracted interest for use as natural food additives in order to

83

prevent the growth of foodborne pathogens or to delay the onset of food spoilage in

84

substitution to chemical preservatives [7]. Bacteria such as Salmonella sp. constitutes a

85

major public health problem in many countries and millions of cases of salmonellosis

86

are noticed worldwide [13]. The Listeria monocytogenes and Escherichia coli are

87

among the major foodborne bacteria implicated in produce outbreaks [14]. The S.

88

aureus is one of the most important foodborne pathogen responsible for two-thirds of

89

global foodborne disease outbreaks [15]. Besides, this bacterium produces heat stable

90

enterotoxins responsible for foodborne intoxications [16]. The Bacillus cereus is a

91

spore-forming, opportunistic Gram-positive bacterium, which produces emetic toxin

92

and enterotoxins and causes food poisoning, including vomiting and diarrhea,

93

particularly after the consumption of rice-based dishes [17]. The genus Bacillus

94

including Bacillus cereus or Bacillus subtilis may be present in fresh and pasteurised

95

food products due to their ability to generate heat-resistant spores under adverse

96

environmental conditions [18]. Despite, the B. subtilis has not been considered a human

97

pathogen, some strains of this species may occasionally cause food poisoning, such as

98

the 2005 outbreak in a kindergarten caused by milk powder [19]. The E. faecalis is a

99

microorganism of the normal intestinal flora in humans and animals, ranked second or

100

third in frequency among bacteria isolated from hospitalized patients. This bacterium

101

has resistance to pasteurization temperatures and ability to adapt to different substrates

102

and environmental conditions. As consequence, it can be found in food products

103

manufactured from raw materials (milk or meat) and in heat-treated food products.

104

[20,21]. The S. marcescens is a Gram-negative bacterium that belongs to

AC C

EP

TE D

M AN U

SC

RI PT

82

4

ACCEPTED MANUSCRIPT Enterobacteriaceae family, considered an opportunist pathogen causing nosocomial

106

infections [22]. Whereas the need for new methods of reducing or eliminating

107

foodborne pathogens, this is the first study that investigated the in vitro antimicrobial

108

activity of Myrcia ovata Cambessedes EOs alone or in combination from plants

109

collected in the state of Sergipe (Brazil) against eight foodborne bacteria.

RI PT

105

110

2. Materials and Methods

113

2.1 Essential oils

SC

111 112

Nine Myrcia ovata Cambessedes (MYRO) essential oils (MYRO-154, MYRO-

115

155, MYRO-156, MYRO-157, MYRO-158, MYRO-159, MYRO-173, MYRO-174 and

116

MYRO-175) were provided by Department of Agronomy of Federal University of

117

Sergipe. The plants were collected in the municipality of Japaratuba, State of Sergipe,

118

Brazil, in November 2013. The locality presents sandy coastal dune vegetation, tropical

119

rainy climate, with annual average temperature of 25.3°C, and average annual rainfall of

120

1628.8 mm [23]. Exsiccates of all plants were deposited in the herbarium of the Federal

121

University of Sergipe, and identification of the species was done by the Myrtaceae

122

taxonomist Dr. Marcos Eduardo Guerra Sobral according Table 1. The essential oils

123

were extracted by hydrodistillation using a modified Clevenger apparatus and the

124

chemical composition was determined by Sampaio et al. [12] as shown in Table 2.

125

2.2 Microorganisms

TE D

EP

AC C

126

M AN U

114

Pseudomonas aeruginosa (INCQS 00025), Staphylococcus aureus (INCQS

127

00014), Bacillus cereus (INCQS 00003), Bacillus subtilis (INCQS 00002),

128

Enterecoccus faecalis (INCQS 00531), Serratia marcescens (INCQS 00131),

129

Escherichia coli (INCQS 00032) and Salmonella enteritidis (INCQS 00258) were

130

purchased from the National Institute of Health and Quality Control/Oswaldo Cruz 5

ACCEPTED MANUSCRIPT 131

Foundation (Manguinhos, Rio de Janeiro, Brazil). The strains were stored in Brain

132

Heart Infusion (BHI) broth with 20% glycerol in a -80°C Ultrafreezer. All culture media

133

were purchased from Oxoid (Brazil).

134

2.3 Antibacterial activity by disk diffusion assay The antibacterial activity of EOs was determined using the disk diffusion

136

method (in triplicate) as described by the Clinical and Laboratory Standards Institute

137

[24]. Solutions containing 1.5 x 108 of each type of bacteria per mL were prepared to

138

0.5 standard of McFarland’s tube. Petri plates containing 20mL of Muller-Hinton agar

139

were inoculated with bacterial solutions. Sterile filter paper disks (6 mm) with 10 µL of

140

EOs were placed on the agar surface using sterile forceps (four disks on each plate). The

141

antibiotics, gentamicin (30 µg/disk) and chloramphenicol (30 µg/disk), were used as

142

positive controls. Plates were incubated at 37°C for 24 h. Following incubation, the

143

diameter (in mm) of the inhibition zone, including the disk diameter, was measured with

144

a calliper. Sensitivity of bacteria to EOs was assessed by measuring the diameter of

145

inhibition zone and bacteria were classified into four groups: not sensitive (diameter < 8

146

mm); sensitive (diameter between 9.0 and 14.0mm); very sensitive (diameter between

147

15.0 and 19.0 mm); and extremely sensitive (diameter > 20 mm) [25].

SC

M AN U

TE D

EP

148

RI PT

135

2.4 Determination of minimum inhibitory concentration (MIC) and minimum

150

bactericidal concentration (MBC)

151

AC C

149

The determination of the minimum inhibitory concentration (MIC) and

152

minimum bactericidal concentration (MBC) was performed using the broth

153

microdilution method according to Clinical and Laboratory Standards Institute [24].

154

EOs were diluted with 1% dimethyl sulfoxide solution to obtain concentrations from

155

0.78 to 400 µL/mL. Cultures of each bacterial strain were obtained from 24 h broth 6

ACCEPTED MANUSCRIPT cultures and adjusted to 0.5 McFarland standard turbidity (1 x 108 CFU/mL). Bacterial

157

suspensions were then diluted to 1 x 106 CFU/mL in Mueller-Hinton broth. 100 µL of

158

EO dilutions were placed into a 96‐well microplate inoculated with 100 µL of each

159

bacterial strain. The microplate was incubated aerobically for 24 h at 37°C. Mueller-

160

Hinton medium incubated with a target bacterium (without EO) was used as a positive

161

control. The MIC was defined as the lowest concentration of EO required for preventing

162

visible bacterial growth. Muller-Hinton broth and bacterial suspension were used as

163

negative and positive controls, respectively. The MBC was determined by sub-culturing

164

100µL aliquots from MIC wells with no visible growth onto Muller-Hinton agar plates

165

and incubating at 37ºC for 24h. The lowest concentration that yielded no visible

166

colonies was considered the MBC.

167

2.5 The checkerboard method

M AN U

SC

RI PT

156

The checkerboard method was performed using 96-well microtitre plates to

169

obtain the fractional inhibitory concentration index (FICI) [26, 27]. The combinations

170

were performed between two EOs (MYRO A and MYRO B) with stronger and weaker

171

potential of inhibition against less susceptible bacteria. The assay was arranged as

172

follows: MYRO-A was diluted two-fold in vertical orientation, while MYRO B was

173

diluted two-fold in horizontal orientation. The EOs concentrations were prepared

174

according to 1, 1/2, 1/4, 1/8, 1/16 and 1/32 of the MIC values. The final volume in each

175

well was 100 µl comprising 50 µl of each EO dilution. After this, 100 µl of media

176

containing 1 × 106 CFU/ml of the indicator strain were added to all wells. The plates

177

were then incubated at 37°C for 24 h. The FICI were calculated as FICMYRO

178

FICMYRO B, where FICMYRO A = MICMYRO A of the combination/MICMYRO A alone and

179

FICMYRO

AC C

EP

TE D

168

B

= MICMYRO

B

of the combination/MICMYRO

B

A

+

alone. The results were

7

ACCEPTED MANUSCRIPT 180

interpreted as synergy (FICI<0.5), addition (0.5≤FIC≤1), indifference (1
181

antagonism (FIC>4).

182 183

2.6 Statistical analysis One-way analysis of variance (ANOVA) was applied to the data to determine

185

differences (p<0.05). Statistical analyses were performed using Assistat program 7.7

186

Beta.

RI PT

184

3. Results and Discussion

189

3.1 Antibacterial activity by disk diffusion assay

M AN U

188

SC

187

The in vitro antibacterial activities of EOs were evaluated by the disk diffusion

191

method against eight foodborne bacteria. The diameters of inhibition zone of EOs

192

ranged from 6.0 to 32.0 mm (Table 3). Among the gram-positive bacteria, S. aureus was

193

sensitive to the majority of EOs, very sensitive to MYRO-156 and extremely sensitive

194

to MYRO-154 and MYRO-157 EOs. The MYRO-154 EO showed a similar inhibition

195

to the antibiotic chloramphenicol without any significant difference (p<0.05), and was

196

significantly higher than that obtained by MYRO-157 (p<0.05).

EP

TE D

190

B. cereus was extremely sensitive to MYRO-157 EO and to antibiotics.

198

However, the antibiotics were more effective to inhibit the bacterial activity. Moreover,

199

the bacterium was also very sensitive to five EOs (MYRO-158, MYRO-173, MYRO-

200

159, MYRO-174 and MYRO-175). B. subtilis was extremely sensitive to MYRO-154,

201

MYRO-157 and MYRO-174 EOs and antibiotics. However these EOs showed

202

statistically significant differences in antibacterial activity (p<0.05). The MYRO-157

203

EO

204

chloramphenicol) to inhibit B. subtilis. This bacterium was also very sensitive to

AC C

197

was

particularly

more

effective

than

the

antibiotics

(gentamicin

and

8

ACCEPTED MANUSCRIPT MYRO-155, MYRO-156, MYRO-159, MYRO-173 and MYRO-175 and sensitive to

206

MYRO-158 EO. For E. faecalis, the EOs showed significant differences in

207

antimicrobial activity (p<0.05). The bacteria was extremely sensitive to MYRO-154,

208

MYRO-175 and to antibiotics, very sensitive to MYRO-157 and sensitive to MYRO-

209

156, MYRO-173 and MYRO-174 EOs.

RI PT

205

From gram-negative bacteria group, P. aeruginosa was the most susceptible to

211

EOs with diameters of the inhibition zone ranging from 11.0 to 32.0 mm. The

212

antimicrobial activities of the EOs did differ statistically (p<0.05), except to MYRO-

213

155 and MYRO-156. This bacterium was sensitive, very sensitive and extremely

214

sensitive to two (MYRO-154 and MYRO-158), five (MYRO-155, MYRO-156,

215

MYRO-159, MYRO-173 and MYRO-175) and two (MYRO-157 and MYRO-174)

216

EOs, respectively. Moreover, the P. aeruginosa showed only a soft sensitivity to

217

chloramphenicol antibiotic. This bacterium is known to have a high level of intrinsic

218

resistance to virtually all known antimicrobials and antibiotics, due to a very restrictive

219

outer membrane barrier, highly resistant even to synthetic drugs [4,28]. The S.

220

marcensces was only sensitive to MYRO-175 EO. However, the antibiotics were

221

effective against this bacterium, which was very sensitive and extremely sensitive to

222

gentamicin and chloramphenicol, respectively. E. coli was sensitive to MYRO-154,

223

MYRO-155 and MYRO-157 EOs, which did differ statistically in antimicrobial activity

224

(p<0.05) and extremely sensitivity to chloramphenicol. The S. enteritidis was sensitive

225

to five EOs (MYRO-154, MYRO-155, MYRO-156, MYRO-157 and MYRO-174).

226

However, this bacterium showed more sensitivity to antibiotics (p<0.05), being

227

extremely sensitive to gentamicin. The results showed that Gram-positive bacteria were

228

the most susceptible to EOs that Gram-negative bacteria in accordance with the

229

literature [1]. The Gram-negative bacteria should be more resistant to EOs due the

AC C

EP

TE D

M AN U

SC

210

9

ACCEPTED MANUSCRIPT 230

hydrophilic cell wall which prevents the penetration of hydrophobic compounds

231

[8,29,30]. Particularly, three (S. aureus, B. subtilis and E. faecalis) and four bacteria (S.

233

aureus, B. cereus, B. subtilis and P. aeruginosa) were extremely sensitive to MYRO-

234

154 and MYRO-157 EOs, respectively. The strong antibacterial activity of these EOs

235

may be due to the presence of monoterpenes geranial and neral, and sesquiterpene (E)-

236

nerolidol. Tyagi et al. [31] correlated the highest antifungal activity of lemon grass EO

237

to the presence of high level of oxygenated monoterpenes (78.2%) constituted by

238

geranial (α-citral) and neral (β-citral) as its major components. The antimicrobial action

239

of monoterpenes suggests that they diffuse into and damage cell membrane structures

240

[32,33]. Nerolidol is also well known for their antibacterial activity [34,35]. Bonikowisk

241

et al. [36] have shown the antimicrobial activity of this compound against

242

Staphylococcus aureus, Enterococcus faecalis, Enterococcus faecium, Escherichia coli,

243

Klebsiella pneumoniae and Acinetobacter baumannii.

TE D

M AN U

SC

RI PT

232

Also, two (B. subtilis and P. aeruginosa) and one bacterium (E. faecalis) were

245

extremely sensitive to MYRO-174 and MYRO-175 EOs, respectively. The MYRO-174

246

EO contains the major compounds linalool, isopulegol and iso-isopulegol and MYRO-

247

175 linalool and nerolic acid. Others 3 EOs (MYRO-155, MYRO-158 and MYRO-159)

248

also contains nerolic acid as major compounds. EOs of Myrtaceae family such as

249

Eucalyptus citriodora, which possess citronellal, citronellol and isopulegol as major

250

compounds, showed fungicidal activity against Candida albicans and bacteriostatic

251

against E. coli and S. aureus [37]. Sampaio et al. [12] published the first report about

252

the presence of the nerolic acid compound in M. ovata EOs. The authors attributed the

253

antifungal activity of these oils against Fusarium solani due to presence of this one and

AC C

EP

244

10

ACCEPTED MANUSCRIPT 254

others major compounds such as linalool, geraniol, neral, geranial, (E)-nerolidol, 1,8-

255

cineole and isopulegol. Cândido et al. [11] have showed similar potential of Myrcia ovata EO, from

257

plants cultivated in Guaramiranga at Ceará State, to inhibit S. aureus and E. faecalis.

258

However, differences were observed for inhibit E. coli and P. aeruginosa, the latter

259

being more susceptible to EOs of this work. These results may be attributed to variation

260

on chemical composition of EOs. Researchers have reported that the great diversity in

261

the chemical composition of essential oils of a single species may be caused by genetic

262

and/or environmental factors [12,38,26]. Environmental factors such as soil, lumi-

263

nosity, and precipitation may affect the availability of nutrients for plants in different

264

locations within the same population and, consequently, influence the content and

265

quality of secondary metabolites within a community or population [39,40]. The

266

reproductive biology of M. ovata is another factor to be considered. It is believed that

267

the reproduction between plants of this species occurs by cross pollination as detected in

268

other species of the same genus, such as Myrcia tomentosa and Myrcia rostrata [41].

269

Cross pollination enables M. ovata plants, in a natural environment, to generate a wide

270

variety of compounds for having received genetic information of plants which are

271

genetically distinct regarding their ability to synthesize certain substances [12].

SC

M AN U

TE D

EP

AC C

272

RI PT

256

273

3.2 Minimum inhibitory concentrations (MIC) and minimum bactericidal

274

concentrations (MBC) of essential oils

275

The MICs and MBCs of MYRO EOs are shown in Tables 4 and 5, respectively.

276

The results show that gram-positive bacteria were more susceptible to essential oil than

277

gram-negative bacteria in accordance with disk diffusion tests. P. aeruginosa was the

278

bacterium most susceptible to MYRO-154, MYRO-159, MYRO-174 and MYRO-175 11

ACCEPTED MANUSCRIPT EOs, which not showed significant differences of inhibition (p>0.05), with MIC values

280

of 0.78 µL/mL. Also, B. cereus, B. subtilis and E. faecalis were inhibited with 0.78

281

µL/mL of MYRO-154, MYRO-174 and MYRO-156 EOs, respectively. S. marcensces,

282

E. coli and S. enteritidis were more susceptible to MYRO-174 EO with MIC values of

283

12.5, 6.25 and 6.25 µL/mL, respectively.

RI PT

279

Regarding to bactericidal activity, the MYRO-154 EO showed efficiency to

285

eliminate B. cereus and S. aureus with the lowest MBC values of 3.13 and 6.25 µL/mL,

286

respectively. The MYRO-154, MYRO-157 and MYRO-174 EOs showed potential to

287

eliminate B. subtilis with 12.5 µL/mL without any significant difference (p>0.05). The

288

MYRO-174 EO was more effective to eliminate E. faecalis, E. coli and P. aeruginosa

289

with the lowest bactericide concentrations of 25 and 6.25 µL/mL, respectively. These

290

results proved the greater antibacterial potential of MYRO EOs in comparison with the

291

oil used by Cândido et al. [11], which MIC and MBC values were 31, 1000 µg/mL and

292

>1000 µg/mL against E. faecalis, E. coli and P. aeruginosa, respectively. On the other

293

hand, both MYRO-174 and MYRO-175 EOs showed similar ability to eliminate S.

294

marcensces and S. enteritidis (p>0.05) with MBC of 25 µL/mL. All bacteria were less

295

susceptible to MYRO 159 EO since the MBC values were >400 µL/mL.

EP

TE D

M AN U

SC

284

There is no unanimity on the MIC value acceptable for natural products when

297

compared with standard antibiotics. Some researchers consider only products with MIC

298

values similar to that of antibiotics, while others consider as good antimicrobial agents

299

even those with higher levels of inhibitions [42]. Aligiannis et al. [43] proposed a

300

classification for plant material antimicrobial activity on the basis of MIC results: strong

301

inhibition for MIC values < 500 µg/mL; moderate inhibition for MIC values between

302

600-1500 µg/mL; and weak inhibition for MIC values > 1600 µg/mL. According to this

AC C

296

12

ACCEPTED MANUSCRIPT 303

classification system, all MYRO EOs had strong inhibition against tested bacteria in this

304

study.

305 306

3.3. Synergistic effect between essential oils The bacteria S. marcensces and E. coli were less susceptible to seven EOs. Then

308

the synergistic effect between the EOs was investigated by checkerboard test (Table 6),

309

where the MYRO-174 was used in all combinations since that inhibited alone these

310

bacteria with the lowest MIC values. All tested combinations displayed a synergism

311

(FICI value ≤ 0.50) for S. marcensces and for E. coli, except the combination of

312

MYRO-174 and MYRO-158 that was indifferent for E. coli. In addition, the test strains

313

were inhibited with lower concentrations of EOs in the combinations than those used

314

with them alone. These results could be explained as reported by Burt [4] and Ultee et

315

al. [44] which have suggested that the minor components present in the EOs are more

316

critical to the activity than EOs main components mixed, and the combination of major

317

components with other minor components that have a weaker activity may achieve a

318

synergistic effect.

319

4. Conclusions

EP

TE D

M AN U

SC

RI PT

307

The present study showed the antimicrobial potential of nine MYRO EOs

321

against eight foodborne bacteria. The pathogenic bacteria were from sensitive to

322

extremely sensitive to EOs and gram-positive were more susceptible than gram-negative

323

bacteria. The EOs showed to be effective bactericides, since all bacteria could be

324

eliminated with MBC values ranging from 3.13 to 25 µL/mL. It was interesting to show

325

that the majority of EOs were able to inhibit and eliminate P. aeruginosa, since that this

326

bacterium has been resistant to others EOs and antibiotics. Furthermore, EOs

327

combinations promoted a synergistic effect against S. marcensces and E. coli, which

AC C

320

13

ACCEPTED MANUSCRIPT 328

showed less susceptible to EOs alone. The Myrcia ovata Cambessedes EO alone or in

329

combination showed potential as natural antimicrobial agent for future studies in food

330

systems.

331

Acknowledgments

RI PT

332

The authors thank the Fundação de Apoio à Pesquisa e à Inovação Tecnológica

334

do Estado de Sergipe (FAPITEC, Sergipe, Brazil) for financial support, and the

335

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, Brazil) for

336

providing a scholarship for the first author.

M AN U

SC

333

337

References

339

[1] J.R. Calo, P.G. Crandall, C.A. O'Bryan, S.C. Ricke, Essential oils as antimicrobials

340

in food systems- A Review. Food Control 54 (2015) 111-119.

341

TE D

338

[2] S.S. Mahmoud, R.B. Croteau, Strategies for transgenic manipulation of

343

monoterpene biosynthesis in plants. Trends Plant Sci. 7 (2002) 366-373.

344

EP

342

[3] F. Bakkali, S. Averbeck, D. Averbeck, M. Idaomar, Biological effects of essential

346

oils e a review. Food Chem Toxicol. 46 (2008) 446-447.

347

AC C

345

348

[4] S. Burt, Essential oils: their antibacterial properties and potential applications in

349

foods—a review. Int. J. Food Microbiol. 94 (2004) 223– 253.

350

14

ACCEPTED MANUSCRIPT 351

[5] M. Li, A. Muthaiyan, C.A. O'Bryan, J.E. Gustafson, Y. Li, P.G. Crandall, S.C.

352

Riche, Use of natural antimicrobials from a food safety perspective for control of

353

Staphylococcus aureus. Curr. Pharm. Biotechnol. 12 (2011) 1240-1254.

354

[6] V.K. Bajpai, K.-H. Baek, S.C. Kang, Control of Salmonella in foods by using

356

essential oils: a review. Food Res Int. 45 (2012) 722-734.

357

RI PT

355

[7] H. Miladi, D. Mili, R.B. Slama, S. Zouari, E. Ammar, A. Bakhrouf, Antibiofilm

359

formation and anti-adhesive property of three mediterranean essential oils against a

360

foodborne pathogen Salmonella strain. Microb. Pathog. 93 (2016) 22-31.

M AN U

SC

358

361

[8] N. Chorianopoulos, E. Kalpoutzakis, N. Aligiannis, S. Mitaku, G.-J. Nychas, S.A.

363

Haroutounian, Essential oils of Satureja, Origanum, and Thymus species: chemical

364

composition and antibacterial activities against foodborne pathogens. J. Agri. Food

365

Chem. 52 (2004) 8261-8267.

TE D

362

366

[9] E.J. Lucas, K. Matsumoto, S.A. Harris, E.M.N. Lughadha, B. Benardini, M.W.

368

Chase, Phylogenetics, morphology, and evolution of the large genus Myrcia s.l.

369

(Myrtaceae). Int. J. Plant Sci 172 (2011) 915–934.

AC C

370

EP

367

371

[10] S.G. Wubshet, H.H. Moresco, Y. Tahtah, I.M.C. Brighente, D. Staerk, High-

372

resolution

373

Glucosidase inhibitors and acetylated ellagic acid rhamnosides from Myrcia palustris

374

DC. (Myrtaceae). Phytochemistry 116 (2015) 246–252.

bioactivity profiling combined

with

HPLC–HRMS–SPE–NMR:

a-

375 15

ACCEPTED MANUSCRIPT 376

[11] C.S. Cândido, C.S.A. Portella, B.J. Laranjeira, S.S. Silva, A.M.C. Arriaga, G.M.P.

377

Santiago, G.A. Gomes, P.C. Almeida, C.B.M. Carvalho, Effects of Myrcia ovata

378

cambess. Essential oil on planktonic growth of gastrointestinal microorganisms and

379

biofilm formation of enterococcus faecalis. Braz. J. Microb. (2010) 41, 621-627.

RI PT

380

[12] T.S. Sampaio, D.A.C. Nizio, L.A.S. White, J.O. Melo, C.S. Almeida, M.F. Alves,

382

P.R. Gagliardi, M.F. Arrigoni-Blank, A.W. Junior, M.E.G. Sobral, A.F. Blank,

383

Chemical diversity of a wild population of Myrcia ovata Cambessedes and antifungal

384

activity against Fusarium solani. Ind. Crop. Prod. 86 (2016) 196–209.

SC

381

M AN U

385 386

[13] N.S.S. Uchida, R. Grespan, M. Piovezan, E.C. Ferreira, M. Machinski Júnior,

387

R.K.N. Cuman, J.M.G. Mikcha, Effect of carvacrol on Salmonella saint paul biofilms

388

on stainless steel surface, Trop. J. Pharm. Res. 13 (12) (2014) 2021-2025

TE D

389

[14] K. Bhargava, D.S. Conti, S.R.P. Rocha, Y. Zhang, Application of an oregano oil

391

nanoemulsion to the control of foodborne bacteria on fresh lettuce. Food Microbiol. 47

392

(2015) 69-73.

393

EP

390

[15] Y. Le Loir, F. Baron, M. Gautier, Staphylococcus aureus and food poisoning,

395

Genet. Mol. Res. 31 (2003) 63–76.

396

AC C

394

397

[16] M.A. Argudin, M.C., Mendoza, M.R. Rodicio, Food poisoning and Staphylococcus

398

aureus enterotoxins, Toxins 2 (2010) 1751–1773

399

16

ACCEPTED MANUSCRIPT 400

[17] E. Bottone, Bacillus cereus, a volatile human pathogen, Clin. Microbiol. Ver. 23

401

(2010) 382–398.

402

[18] I.C. Fernández-No, M. Guarddon, K. Böhme, A. Cepeda, P. Calo-Mata, J. Barros-

404

Velázquez, Detection and quantification of spoilage and pathogenic Bacillus cereus,

405

Bacillus subtilis and Bacillus licheniformis by real-time PCR. Food Microbiol. 28

406

(2011) 605-610.

RI PT

403

SC

407

[19] S. Pavic, M. Brett, N. Petric, D. Lastre, M. Smoljanovic, M. Atkinson, An outbreak

409

of food poisoning in a kindergarten caused by milk powder containing toxigenic

410

Bacillus subtilis and Bacillus licheniformis. Archiv für Lebensmittelhygiene 56 (2005)

411

20-22.

M AN U

408

412

[20] H. Drahovská, L. Slobodníková, D. Kocíncová, J. Trupl, J. Turna, Antibiotic

414

resistance and virulence factors among clinical and food Enterococcus isolated in

415

Slovakia. Folia Microbiol. (Praha) 49 (2004) 763-768.

EP

416

TE D

413

[21] FH, Kayser, Safety aspects of Enterococcus from the medical point of view. Int J

418

Food Microbiol. 88 (2003) 255–263.

419

[22] A. Hejazi, F.R. Falkiner, Serratia marcescens, Med. Microbiol. 46 (1997) 903-912.

420

AC C

417

421

[23] A.P.N., Prata, M.C.E., Amaral, M.C.V., Farias, M.V., Alves, Flora de Sergipe 1.

422

Editora Trinho, Sergipe (2013).

423

17

ACCEPTED MANUSCRIPT 424

[24] Clinical and Laboratory Standards Institute (CLSI). Performance standards for

425

antimicrobial disk susceptibility tests; approved standard: eleventh edition, M02-11.

426

Wayne, PA: CLSI. (2012).

427

[25] D. Djenane, J. Yangüela, L. Montañés, M. Djerbal, P. Roncalés, Antimicrobial

429

activity of Pistacia lentiscus and Satureja montana essential oils against Listeria

430

monocytogenes CECT 935 using laboratory media: Efficacy and synergistic potential in

431

minced beef. Food Control 22 (2011) 1046-1053.

SC

RI PT

428

432

[26] Z. Schelz, J. Molnar, J. Hohmann, Antimicrobial and antiplasmid activities of

434

essential oils, Fitoterapia 77 (2006) 279–328.

M AN U

433

435

[27] I.H.N. Bassolé, A. Lamien-Meda, B. Bayala, L.C. Obame, A.J. Ilboudo, C. Franz,

437

J. Novak, R.C. Nebié, M.H. Dicko, Chemical composition and antimicrobial activity of

438

Cymbopogon citratus and Cymbopogon giganteus essential oils alone and in

439

combination. Phytomedicine 18 (2011) 1070-1074.

EP

440

TE D

436

[28] C.M. Mann, S.D. Cox, J.L. Markham, The outer membrane of Pseudomonas

442

aeruginosa NCTC6749 contributes to its tolerance to the essential oil of Melaleuca

443

alternifolia (tea tree oil). Lett. Appl. Microbiol. 30 (2000) 294–297.

444

AC C

441

445

[29] M. Ravichandran, N.S. Hettiarachchy, V. Ganesh, S.C. Ricke, S. Singh,

446

Enhancement of antimicrobial activities of naturally occurring phenolic compounds by

447

nanoscale delivery against Listeria monocytogenes, Escherichia coli O157:H7 and

18

ACCEPTED MANUSCRIPT 448

Salmonella Typhimurium in broth and chicken meat system. J. Food Safety 31 (2011)

449

462-471.

450

[30] A.A. Almadiy, G.E. Nenaah, B.A. Al Assiuty, E.A. Moussa, N.M. Mira, Chemical

452

composition and antibacterial activity of essential oils and major fractions of four

453

Achillea species and their nanoemulsions against foodborne bacteria. LWT - Food Sci.

454

Technol. 69 (2016) 529-537.

RI PT

451

SC

455

[31] A.K., Tyagi, A., Malik, Liquid and vapour-phase antifungal activities of selected

457

essential oils against Candida albicans: microscopic observations and chemical

458

characterization of Cymbopogon citratus. BMC Complement Altern Med 10:65 (2010)

459

1-11.

M AN U

456

460

[32] M. Meincken, D.L. Holroyd, M. Rautenbach, Atomic force microscopy study of

462

the effects of antimicrobial peptides on the cell envelope of Escherichia coli.

463

Antimicrob. Agents Chemother. 49 (2005) 4085-4092.

TE D

461

EP

464

[33] H.N. Bhatti, S.S. Khan, A. Khan, M. Rani, V.U. Ahmad, M.I. Choudhary,

466

Biotransformation of monoterpenoids and their antimicrobial activities. Phytomedicine,

467

21 (2014) 1597–1626.

468

AC C

465

469

[34] L. Jirovetz, G. Buchbauer, E. Schmidt, A.S. Stoyanova, Z. Denkova, R. Nikolova,

470

M. Geissler, Purity, antimicrobial activities and olfactoric evaluations of geraniol/nerol

471

and various of their derivatives, J. Essent. Oil Res.19 (2007) 288-291.

472 19

ACCEPTED MANUSCRIPT 473

[35] R. Tao, C.-Z. Wang, Z.-W. Kong. Antibacterial/Antifungal Activity and

474

Synergistic Interactions between Polyprenols and Other Lipids Isolated from Ginkgo

475

Biloba L. Leaves. Molecules 18 (2013) 2166-2182.

476

[36] R. Bonikowski, P. Świtakowska, J. Kula, Synthesis, odour evaluation and

478

antimicrobial activity of some geranyl acetone and nerolidol analogues. Flavour Frag. J.

479

30:3 (2015) 238–244.

RI PT

477

SC

480

[37] Y.A., Koudoro, C.P.A., Dossa, B.B., Yèhouénou, F.P., Tchobo, G.A., Alitonou, F.,

482

Avlessi, D.C.K., Sohounhloué, Phytochemistry, antimicrobial and antiradical activities

483

evaluation of essential oils, ethanolic and hydroethanolic extracts of the leaves of

484

Eucalyptus citriodora hook from benin. Scientific Study & Research: Chemistry &

485

Chemical Engineering, Biotechnology, Food Industry 15:1 (2014) 059 – 073.

TE D

M AN U

481

486

[38] A.F. Blank, T.C.P. Sant’ana, P.S. Santos, M.F. Arrigoni-Blank, A.P.N. Prata,

488

H.C.R. Jesus, P.B. Alves, Chemical characterization of the essential oil from patchouli

489

accessions harvested over four seasons. Ind. Crop. Prod. 34 (2011) 831–837.

AC C

490

EP

487

491

[39] A.F. Blank, L.C.A. Camêlo, M.F. Arrigoni-Blank, J.B. Pinheiro, T.M. Andrade,

492

E.S. Niculau, P.B. Alves, Chemical diversity in Lippia alba (Mill.) N.E. brown. Sci.

493

World J. (2015) 1–11.

494 495

[40] A.K. Broz, C.D. Broeckling, C. Pena, M.R. Lewis, E. Greene, R.M. Callaway,

496

L.W. Sumner, J.M. Vivanco, Plant neighbor identity influences plant biochemistry and

497

physiology related to defense. BMC Plant Biol. 10 (2010) 115–128. 20

ACCEPTED MANUSCRIPT 498 499

[41] H.M., Torezan-Silingardi, P.E.A.M., Oliveira, Phenology and reproductive ecology

500

of Myrcia rostrata and M. tomentosa (Myrtaceae) in central Brazil. Phyton 44 (2004)

501

23–43.

RI PT

502

[42] U.N. Aguiar, S.G. Lima, M.S. Rocha, A.M.G.L. Citó, A.J.P. Sousa, R.M. Silva,

504

I.S.A. Silva, J.G.M. Costa, Chemical composition and modulation of antibiotic activity

505

of essential oil of Lantana caatingensis M. (Verbenaceae). Ind. Crop. Prod. 74 (2015)

506

165-170.

SC

503

M AN U

507 508

[43] N. Aligiannis, E. Kalpotzakis, S. Mitaku, I.B. Chinou, Composition and

509

antimicrobial activity of the essential oil of two Origanum species. J. Agri. Food Chem.,

510

40 (2001) 4168-4170.

TE D

511

[44] A. Ultee, E.P.W. Kets, M. Alberda, F.A. Hoekstra, E.J. Smid, Adaptation of the

513

food-borne pathogen Bacillus cereus to carvacrol. Arch. Microb. 174 (2000) 233-238.

515 516 517

AC C

514

EP

512

21

ACCEPTED MANUSCRIPT Table 1 Geographic data of Myrcia ovata Cambessedes plants collected in Japaratuba, Sergipe State Brazil (Sampaio et al., 2016) Plant code Geographic date Herbarium code o o MYRO-154 10 37' 38.1"S; 36 53' 16.8"W 33.830 MYRO-155

10o 37' 38.0" S; 36o 53' 17.4" W

MYRO-156

10o 37' 38.7" S; 36o 53' 19.6" W

MYRO-157

10o 37' 38.8" S; 36o 53' 19.9" W

MYRO-158

10o 37' 37.6" S; 36o 53' 18.5" W

MYRO-159

10o 37' 37.2" S; 36o 53' 17.5" W

33.845

MYRO-173

10o 37' 38.5" S; 36o 53' 21.9" W

33.828

MYRO-174

10o 38' 45.4" S; 36o 52' 16.9" W

35.709

MYRO-175

10o 38' 44.8" S; 36o 52' 17.7" W

33.827

RI PT

33.833

33.835 33.839

AC C

EP

TE D

M AN U

SC

33.842

ACCEPTED MANUSCRIPT

Table 2 Chemical composition (%) of Myrcia ovata Cambessedes essential oils (MYRO) obtained by hydrodistillation. Composition (%) MYROMYRO157 158 0.35 0.65 0.50 0.98 0.28 0.30 4.36 5.11 5.77 2.89 1.76 1.00 1.38 5.02 0.86 18.21 1.87 0.70 0.92 36.96 2.90 50.02 1.12 1.29 0.43 1.53 20.24 0.80 0.97 1.10 16.65 3.03 93.76 96.18

RI PT

MYROMYRO155 156 α-Pinene 932 933 0.44 0.30 β-Pinene 974 974 0.32 0.95 0.29 p-Cymene 1020 1020 0.23 1,8-Cineole 1026 1026 0.75 4.65 1.38 Linalool 1095 1095 0.53 1.20 7.56 Isopulegol 1145 1145 2.30 Citronellal 1148 1148 9.19 Iso-Isopulegol 1155 1155 1.40 Terpinen-4-ol 1174 1174 0.79 1.41 α-Terpineol 1186 1186 1.01 1.26 2.24 Citronellol 1223 1223 3.27 Neral 1235 1235 0.34 0.11 28.39 Geraniol 1249 1249 1.33 74.37 Methyl citronellate 1257 1257 1.33 Geranial 1264 1265 0.16 1.93 40.10 Methyl nerolate 1280 1280 1.74 Citronellic acid 1312 1315 Nerolic acid 1347 1346 67.87 Geronic acid 1375 1376 1.88 (E)-Caryophyllene 1417 1422 0.51 0.18 0.74 β-Selinene 1489 1490 1.61 0.94 α-Selinene 1498 1498 1.43 0.91 (E)-Nerolidol 1561 1562 1.02 Caryophyllene oxide 1582 1585 0.93 0.35 1.47 β-Bisabolene 1674 1673 3.38 (2E, 6Z)-Farnesol 1714 1715 1.30 (2Z, 6E)-Farnesol 1722 1723 0.44 3.32 (2E, 6E)-Farnesol 1742 1742 0.55 (2E, 6E)-Farnesal 1740 1745 Total identified 95.36 90.87 93.90 RRIlit: Relative Retention Index-Literature; RRIexp.: Relative Retention Index – Experimental

SC

MYRO154

M AN U

RRIexp

TE D

RRILit.

EP

Compounds

AC C



MYRO159 0.26 3.98 1.40 0.72 1.64 1.28 73.97 1.63 1.29 0.50 2.05 0.27 5.38 94.37

MYRO173 3.89 2.01 3.13 33.03 0.44 7.77 7.42 1.31 1.86 25.62 0.82 2.44 1.36 0.88 91.98

MYRO174 0.86 1.04 0.66 2.88 19.61 27.50 10.29 2.71 2.33 2.71 0.14 0.45 0.10 0.10 0.71 6.33 1.19 1.68 1.40 0.29 1.92 5.69 0.43 91.03

MYRO175 0.82 0.81 0.21 8.68 14.97 1.17 4.60 0.23 1.61 1.21 52.61 0.88 3.61 3.51 0.66 95.58

ACCEPTED MANUSCRIPT

M AN U

SC

RI PT

Table 3 Diameters of inhibition zone (including paper disc diameter of 6.0 mm) of Myrcia ovata Cambessedes (MYRO) EOs against foodborne bacteria and antibiotics used as a positive control. Diameters of inhibition zone (mm) (Mean ± Standard Deviation) Bacterium Essential oils Standard antibiotics MYROMYROMYROMYRO- MYROMYROMYROMYROMYROGEN CHLOR 154 155 156 157 158 159 173 174 175 27.5±3.5a S. aureus 28.5±1.2a 13.0±1.5f 16.0±1.0d 20.0±2.0c 11.5±0.5g 12.5±0.5fg 11.0±0.0g 14.0±2.5e 12.5±0.7f 26.5±3.5b B. cereus 13.5±0.5f 10.0±0.8g 13.0±0.8f 20.0±0.0c 16.5±0.9d 15.0±1.4e 17.0±1.0d 15.5±0.7e 15.0±1.4e 24.0±2.3b 25.5±0.7a b i g a j f h d e B. subtilis 25.0±2.0 16.0±0.0 17.0±2.0 30.0±2.5 13.5±0.5 17.5±1.5 16.5±0.7 20.0±1.4 18.5±2.0 25.0±0.0b 24.0±0.0c d i f e i j g h a b E. faecalis 20.0±0.0 8.5±0.5 13.0±0.8 17.0±2.0 8.5±0.5 7.5±0.5 12.5±0.7 10.5±0.7 22.0±1.4 21.3±1.2 20.6±0.6c h e e b g f c a d P. aeruginosa 11.0±0.0 16.5±0.5 16.5±1.2 30.0±0.9 13.0±0.5 15.5±0.5 19.0±1.4 32.0±2.5 17.5±0.7 8.0±2.8j 10.5±6.4i d f d e f f e g c b S. marcensces 8.0±0.2 7.0±0.0 8.0±0.4 7.6±0.2 7.0±0.0 7.0±0.2 7.5±0.5 6.0±0.0 11.0±1.4 17.0±3.2 27.0±2.8a b c f d e e f f f e E. coli 10.5±1.2 10.0±0.0 8.0±0.0 9.5±0.5 8.5±0.5 8.6±0.5 8.0±0.0 8.0±0.5 8.0±0.0 8.5±3.5 24.0±1.4a S. enteritidis 13.0±0.8c 9.5±1.2e 9.6±0.5e 10.5±0.5d 8.0±0.0g 8.5 ±0.5f 7.5±0.5h 13.0±3.0c 6.0±0.0i 26.5±2.5a 14.5±1.0b a–j

AC C

EP

TE D

For each bacterium, different letters in the same line indicate significant differences (p < 0.05) between the mean values according to Tukey’s test. GEN: gentamicin antiobiotic (20 µg/disc) CHLOR: Chloramphenicol antibiotic (20 µg/disc)

ACCEPTED MANUSCRIPT

MYRO157 12.5c 12.5c 6.3d 200b 6.25c 200b 200a 25c

MYRO158 25b 50a 12.5c 400a 12.5b 400a 100b 50b

MYRO159 6.25d 25.0b 25.0b 3.13e 0.78e 25.0d 12.5d 6.25e

SC

MYRO156 25b 50a 50a 0.78f 3.13d 50c 100b 12.5d

MYRO173 50a 25b 12.5c 200b 3.13d 400a 100b 25c

MYRO174 6.25d 3.13d 0.78e 12.5d 0.78e 12.5e 6.25e 6.25e

MYRO175 25b 12.5c 12.5c 25c 0.78e 25d 25c 12.5d

EP

TE D

For each bacterium, different letters in the same line indicate significant differences (p < 0.05) between the mean values according to Tukey’s test.

AC C

a–f

MYRO155 50a 50a 6.25d 400a 50a 200b 200a 200a

M AN U

S. aureus B. cereus B. subtilis E. faecalis P. aeruginosa S. marcensces E. coli S. enteritidis

MYRO154 3.13e 0.78e 1.56e 400a 0.78e 50c 12.5d 12.5d

RI PT

Table 4 Minimum inhibitory concentrations (MIC) of Myrcia ovata Cambess. (MYRO) essential oils (µL/mL)

ACCEPTED MANUSCRIPT

M AN U

SC

RI PT

Table 5 Minimum bactericidal concentrations (MBC) of Myrcia ovata Cambess. (MYRO) essential oils (µL/mL) MYRO- MYRO- MYRO- MYRO- MYRO- MYRO- MYRO- MYRO154 155 156 157 158 159 173 174 d a c b a b S. aureus 6.25 200. 25 50 200 >400 50 25c B. cereus 3.13e 50c 200a 50c 25d >400 100b 25d B. subtilis 12.5d 25c 400a 12.5d 100b >400 25c 12.5d a b E. faecalis 100 >400 >400 >400 25d >400 >400 400 P. aeruginosa 25b 100.0a >400 >400 100a >400 >400 6.25c S. marcensces >400 400a >400 400a >400 >400 25c 200b E. coli 50c >400 400a >400 >400 >400 >400 25d a a S. enteritidis >400 >400 >400 >400 >400 100 25b 100 a–e

MYRO175 25c 25d 25c 50c 25b 25c 100b 25b

AC C

EP

TE D

For each bacterium, different letters in the same line indicate significant differences (p < 0.05) between the mean values according to Tukey’s test. Values MBC >400 µL/mL were not considered in the statistical analysis.

ACCEPTED MANUSCRIPT Table 6 FICI values of EOs combinations against S. marcensces and E. coli S. marcensces

Combinations

MYRO 174 – MYRO 158

FICI value

Interaction

0.28

Synergism

0.50

Synergism

0.15

Synergism

0.37

Synergism

0.06

Synergism

-

-

0.06

Synergism

1.03

Indifferent

AC C

EP

TE D

M AN U

MYRO 174 – MYRO 173

Interaction

RI PT

MYRO 174 – MYRO 157

FICI value

SC

MYRO 174 – MYRO 155

E. coli

ACCEPTED MANUSCRIPT

HIGHLIGHTS

Paper : “Myrcia ovata Cambessedes essential oils: A proposal for a novel natural

RI PT

antimicrobial against foodborne bacteria “

SC

- Myrcia ovata Cambessedes essential oil alone or in combination, a potent natural antibacterial. - Foodborne bacteria were from sensitive to extremely sensitive to EOs.

AC C

EP

TE D

M AN U

- Essential oil effective to inhibit P. aeruginosa, usually resistant to antimicrobials.